Status:
COMPLETED
Longitudinal Analysis of the Vaginal Microbiome
Lead Sponsor:
Viome
Conditions:
Vaginal Microbiome
Eligibility:
FEMALE
18+ years
Brief Summary
This is a longitudinal, observational study with the goal of understanding vaginal microbiome changes both within a single day and across a menstrual cycle. The study will be composed of at least 10 w...
Detailed Description
Eligible women will be recruited into the study. They will be consented and asked to complete a health questionnaire. On six separate days during two menstrual cycles, they will be asked to collect va...
Eligibility Criteria
Inclusion
- Biological sex is female
- Willing to collect own vaginal samples
- Willing to answer health questions
- Experience menstrual cycles regularly (a monthly cycle)
Exclusion
- Pregnant
- Antibiotic use in the past 3 months
Key Trial Info
Start Date :
July 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2023
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT05383326
Start Date
July 7 2022
End Date
August 20 2023
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Viome Life Sciences
Bothell, Washington, United States, 98011